SPP1 and B-cell chronic lymphocytic leukemia: A recent study by Dielschneider et al. investigating the use of “lysosomal penetrating” or lysosomotropic agents in CLL uncovered an increase in S1P phosphatase 1 (SPP1) and sphingosine in primary CLL patient samples70 compared to normal B cells.